FDA Clears Acutus Medical AcQCross Suite of Transseptal Crossing Devices
FDA Clears Acutus Medical AcQCross Suite of Transseptal Crossing Devices Product family targets electrophysiology and structural heart procedures April 14, 2021 — The U.S. Food and Drug Administration (FDA) cleared the Acutus Medical AcQCross family of universal transseptal crossing devices. This is the only transseptal puncture system specifically engineered to pair and mate seamlessly with Acutus’ own suite of sheaths and with sheaths sold by other manufacturers. In the United States, there are over 300,000 electrophysiology (EP) and structural heart procedures per year involving the ...